ABC Labs
Ahsan Amjad serves as Co-Founder and CEO of ABC Labs, where an impactful project established the largest pandemic lab in Sweden, achieving approximately 25% of the national capacity, nine publications, and around 180 million USD in revenues, while currently focusing on automated substance abuse screening in workplaces. Ahsan is the Founder of RFB Orient, which is a privately owned portfolio of health innovations. Ahsan also holds board member and investor roles in several organizations, including KRY, which leads as Europe's digital-first healthcare provider with over 10 million patient appointments, and ImagineCare, a care management platform now collaborating with the Swedish public healthcare system. Additional board memberships include Geras Solutions, specializing in cognitive disease prevention and diagnosis, and HerCare Kvinnoklinik, focussing on women's health and hormone replacement therapies. Previous experience includes Co-Founder and CEO of Immune Therapy Holdings and Director of the Indonesia International Institute for Life-Sciences.
This person is not in any teams
This person is not in any offices
ABC Labs
ABC was created in spring 2020 in direct response to unprecedented challenges of the covid 19 pandemic and scaled to become one of the fastest growing companies in Swedish history; in the process creating a unique infrastructure of technology, automated laboratory production, and a network of academics and industrial leaders at the very forefront of science. Now, we are turning our attention to deploying an end-to-end product for substance abuse screening at European workplaces and building a research project utilizing long term multi-omics and biochemistry data to answer fundamental questions about health and human biology, an initiative we believe can become one of the most impactful scientific endeavors in the decade to come.